447 results match your criteria: "University of Maryland Medical School.[Affiliation]"

Peer review is an essential cornerstone of scientific advancement. This process involves understanding study design, data analytics, and interpretation of the evidence. For clinicians who are performing their initial peer reviews, and even for seasoned reviewers who assess complex manuscripts, it can be helpful to have a standard approach.

View Article and Find Full Text PDF

Proper duration of antibiotics after video-assisted thoracoscopic surgery for the treatment of thoracic empyema.

Infect Dis (Lond)

November 2024

Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Background: When chest tube drainage does not adequately resolve thoracic empyema, video assisted thoracoscopic surgery (VATS) is often needed. However, the proper duration of antibiotics after VATS is poorly defined. Consequently, the objective of this study was to evaluate if short antibiotic durations post-VATS was equally effective compared to longer durations.

View Article and Find Full Text PDF

Purpose: Human Papilloma Virus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is a distinct disease from other head and neck tumors. This guideline provides evidence-based recommendations on the critical decisions in its curative treatment, including both definitive and postoperative radiation therapy (RT) management.

Methods: ASTRO convened a task force to address 5 key questions on the use of RT for management of HPV-associated OPSCC.

View Article and Find Full Text PDF

Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.

Adv Drug Deliv Rev

June 2024

Fischell Department of Bioengineering, University of Maryland, College Park, 8278 Paint Branch Drive, College Park, MD 20742, USA; Department of Veterans Affairs, VA Maryland Health Care System, 10. N Green Street, Baltimore, MD 21201, USA; Robert E. Fischell Institute for Biomedical Devices, 8278 Paint Branch Drive, College Park, MD 20742, USA; Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, MD, 21201, USA; Marlene and Stewart Greenebaum Cancer Center, 22 S. Greene Street, Suite N9E17, Baltimore, MD, 21201, USA. Electronic address:

Immunotherapies have been transformative in many areas, including cancer treatments, allergies, and autoimmune diseases. However, significant challenges persist in extending the reach of these technologies to new indications and patients. Some of the major hurdles include narrow applicability to patient groups, transient efficacy, high cost burdens, poor immunogenicity, and side effects or off-target toxicity that results from lack of disease-specificity and inefficient delivery.

View Article and Find Full Text PDF

Fleas transmit directly within the dermis of mammals to cause bubonic plague. Syringe-mediated inoculation is widely used to recapitulate bubonic plague and study pathogenesis. However, intradermal needle inoculation is tedious, error prone, and poses a significant safety risk for laboratorians.

View Article and Find Full Text PDF

Zfp281 and Zfp148 control CD4 T cell thymic development and T2 functions.

Sci Immunol

November 2023

Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

How CD4 lineage gene expression is initiated in differentiating thymocytes remains poorly understood. Here, we show that the paralog transcription factors Zfp281 and Zfp148 control both this process and cytokine expression by T helper cell type 2 (T2) effector cells. Genetic, single-cell, and spatial transcriptomic analyses showed that these factors promote the intrathymic CD4 T cell differentiation of class II major histocompatibility complex (MHC II)-restricted thymocytes, including expression of the CD4 lineage-committing factor Thpok.

View Article and Find Full Text PDF

Inside look: Are noninvasive biomarkers up to standard?

Am J Transplant

March 2024

Surgical Sciences Division, Department of Surgery, University of Maryland Medical School, Baltimore, Maryland, USA. Electronic address:

View Article and Find Full Text PDF

Objective: Studies evaluating the incidence, source, and preventability of hospital-onset bacteremia and fungemia (HOB), defined as any positive blood culture obtained after 3 calendar days of hospital admission, are lacking in low- and middle-income countries (LMICs).

Design, Setting, And Participants: All consecutive blood cultures performed for 6 months during 2020-2021 in 2 hospitals in India were reviewed to assess HOB and National Healthcare Safety Network (NHSN) reportable central-line-associated bloodstream infection (CLABSI) events. Medical records of a convenience sample of 300 consecutive HOB events were retrospectively reviewed to determine source and preventability.

View Article and Find Full Text PDF

Biomaterials allow for the precision control over the combination and release of cargo needed to engineer cell outcomes. These capabilities are particularly attractive as new candidate therapies to treat autoimmune diseases, conditions where dysfunctional immune cells create pathogenic tissue environments during attack of self-molecules termed self-antigens. Here we extend past studies showing combinations of a small molecule immunomodulator co-delivered with self-antigen induces antigen-specific regulatory T cells.

View Article and Find Full Text PDF

Metacognition has been defined several ways across different fields. In schizophrenia, two primary approaches to assessing metacognition focus on measuring metacognitive beliefs and metacognitive capacity. The degree of association between these two approaches is unclear.

View Article and Find Full Text PDF

Exploiting Unique Features of Microneedles to Modulate Immunity.

Adv Mater

December 2023

Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.

Microneedle arrays (MNAs) are small patches containing hundreds of short projections that deliver signals directly to dermal layers without causing pain. These technologies are of special interest for immunotherapy and vaccine delivery because they directly target immune cells concentrated in the skin. The targeting abilities of MNAs result in efficient immune responses-often more protective or therapeutic-compared to conventional needle delivery.

View Article and Find Full Text PDF

Transforming bioengineering with unbiased teams and tools.

Nat Rev Bioeng

March 2023

Fischell Department of Bioengineering, University of Maryland, College Park, MD USA.

Scientific bias originates from both researchers and techniques. Evidence-based strategies to mitigate this bias include the assembly of diverse teams, development of rigorous experimental designs, and use of unbiased analytical techniques. Here, we highlight potential starting points to decrease bias in bioengineering research.

View Article and Find Full Text PDF

Building Sustainable Infection Prevention in the Era of COVID-19.

Health Secur

November 2023

Rebecca Leach, MPH, RN, BSN, CIC, is System Manager of Infection Prevention, CommonSpirit Health, Phoenix, AZ.

View Article and Find Full Text PDF

Background: This cadaveric study seeks to determine whether skills acquired on the simulator translate to improved performance of the clinical task. We hypothesized that completion of simulator training modules would improve performance of percutaneous hip pinning.

Methods: Eighteen right-handed medical students from two academic institutions were randomized: trained (n = 9) and untrained (n = 9).

View Article and Find Full Text PDF

Microneedle arrays (MNAs) are patches displaying hundreds of micron-scale needles that can penetrate skin. As a result, these arrays efficiently and painlessly access this immune cell-rich niche, motivating significant clinical interest in MNA-based vaccines. Our lab has developed immune polyelectrolyte multilayers (iPEMs), nanostructures built entirely from immune signals employing electrostatic self-assembly.

View Article and Find Full Text PDF

Adenovirus (ADV) may cause severe complications in hematopoietic stem cell transplant recipients, but disseminated ADV infections in patients who received chemotherapy alone for hematological malignancies are poorly understood due to the rarity of cases. Concomitant infection with Pneumocystis (PCP) is extremely rare. Despite being diagnostically challenging, a more specific workup needs to be initiated with a low threshold in patients who are exposed to agents with the potential to suppress T cells.

View Article and Find Full Text PDF

Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.

ACS Appl Bio Mater

June 2023

University of Maryland Fischell Department of Bioengineering, University of Maryland, College Park, Maryland 20742, United States.

Immunotherapies are an evolving treatment paradigm for addressing cancer, autoimmunity, and infection. While exciting, most of the existing therapies are limited by their specificity─unable to differentiate between healthy and diseased cells at an antigen-specific level. Biomaterials are a powerful tool that enable the development of next-generation immunotherapies due to their tunable synthesis properties.

View Article and Find Full Text PDF

Objective: Adversarial hearings in hospital commitment and de novo treatment proceedings, or court hearings, delay psychiatric treatment in many jurisdictions. In Massachusetts, the "treatment over objection" process requires a court petition. For state hospital patients, the delay to treatment is an initial 34 day waiting period in addition to continuances of court hearings that extend treatment delays.

View Article and Find Full Text PDF

Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.

Adv Nanobiomed Res

March 2023

Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.

Disease modifying drugs and biologics used to treat autoimmune diseases, although promising, are non-curative. As the field moves towards development of new approaches to treat autoimmune disease, antigen-specific therapies immunotherapies (ASITs) have emerged. Despite clinical approval of ASITs for allergies, clinical trials using soluble ASITs for autoimmunity have been largely unsuccessful.

View Article and Find Full Text PDF

Enhancing the functionality of self-assembled immune signals using chemical crosslinks.

Front Immunol

February 2023

Fischell Department of Bioengineering, University of Maryland, College Park, MD, United States.

Multiple sclerosis (MS) is an autoimmune disease that develops when dysfunctional autoreactive lymphocytes attack the myelin sheath in the central nervous system. There are no cures for MS, and existing treatments are associated with unwanted side effects. One approach for treating MS is presenting distinct immune signals (i.

View Article and Find Full Text PDF

Antigen-specific tolerance is a key goal of experimental immunotherapies for autoimmune disease and allograft rejection. This outcome could selectively inhibit detrimental inflammatory immune responses without compromising functional protective immunity. A major challenge facing antigen-specific immunotherapies is ineffective control over immune signal targeting and integration, limiting efficacy and causing systemic non-specific suppression.

View Article and Find Full Text PDF

Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps.

Adv Sci (Weinh)

March 2023

University of Maryland Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.

Autoimmunity and allergies affect a large number of people across the globe. Current approaches to these diseases target cell types and pathways that drive disease, but these approaches are not cures and cannot differentiate between healthy cells and disease-causing cells. New immunotherapies that induce potent and selective antigen-specific tolerance is a transformative goal of emerging treatments for autoimmunity and serious allergies.

View Article and Find Full Text PDF

Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance.

Adv Healthc Mater

January 2023

Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA.

During autoimmunity or organ transplant rejection, the immune system attacks host or transplanted tissue, causing debilitating inflammation for millions of patients. There is no cure for most of these diseases. Further, available therapies modulate inflammation through nonspecific pathways, reducing symptoms but also compromising patients' ability to mount healthy immune responses.

View Article and Find Full Text PDF

Mapping asymptomatic malaria infections, which contribute to the transmission reservoir, is important for elimination programs. This analysis compared the spatiotemporal patterns of symptomatic and asymptomatic Plasmodium falciparum malaria infections in a cohort study of ∼25,000 people living in a rural hypoendemic area of about 179 km2 in a small area of the Chittagong Hill Districts of Bangladesh. Asymptomatic infections were identified by active surveillance; symptomatic clinical cases presented for care.

View Article and Find Full Text PDF